Pretoria, 12 January 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ). The MoU between SAHPRA and MCAZ will allow the regulators to develop a cooperative partnership towards ensuring access...
There have been several cases around the world in which Tranexamic acid has been administered intrathecally in error instead of the local anaesthetic agent, bupivacaine.(1) Postpartum haemorrhage is the third most common cause of death in obstetric practice in developing countries. Tranexamic acid is life-saving in...
Pretoria, 19 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the product Lubri-A (Sterile Lubricating Jelly) manufactured by Electro-Spyres, classified as Class B medical device and currently being distributed across the country. SAHPRA has been informed of multiple complaints received...
Pretoria, 14 December 2023 -The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of Witwatersrand, is responsive to the evolving and advancing healthcare technology innovation by developing relevant training for its...
Pretoria, 13 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) recently released a media statement on the falsified Ozempic products currently being sold on the market and online, specifically unauthorised Ozempic/semaglutide-containing products. SAHPRA has registered one product which contains semaglutide called Ozempic. There...
The SAHPRA Service Desk is back online. ICT has completed its necessary maintenance, and services have been restored. We sincerely apologise for any inconvenience caused. ...
Pretoria, 11 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the falsified Ozempic products currently being sold on the market and online. SAHPRA has been informed of advertisements regarding unauthorised Ozempic/semaglutide-containing products that are being disseminated through radio stations and...
The SAHPRA Service Desk will be unavailable from Friday, 08 December 2023 until Monday, 11 December 2023 as the ICT team will be performing maintenance. During this time, users will be unable to send queries, lot release applications or respond to existing queries using the system. Users will be...
The establishment of the African Medicines Agency (AMA) will significantly contribute to the improvement of healthcare delivery across the continent and better overall health of African citizens. Africa continues to be a growing continent in many aspects. It is expected that the population of young Africans...
Pretoria, 06 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is currently conducting a Stakeholder Satisfaction Survey through an independent market research agency, MarkData (Pty) Ltd. SAHPRA has commissioned MarkData to conduct these surveys to better understand its effectiveness in implementing its regulatory...
